Bayesian Capital Management, LP Biomarin Pharmaceutical Inc Transaction History

Bayesian Capital Management, LP

  • $854 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $1.64 Million - $2.21 Million
20,304 New
20,304 $2.1 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $180,771 - $219,379
-2,419 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $29,116 - $36,170
-401 Reduced 14.22%
2,419 $212,000
Q3 2020

Nov 12, 2020
BUY
$71.87 - $131.03 $202,673 - $369,504
2,820 New
2,820 $215,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email